Jennifer (“Jenn”) Hartt, MS is the Managing Director of the Healthcare Investment Group at Ben Franklin. Hartt directs all of Ben Franklin’s life sciences related investments in companies with technologies ranging from clinical healthcare IT, medical devices and diagnostics to therapeutics. Hartt has closed 139 investments totaling over $33M in over 70 companies for Ben Franklin since early 2006. Hartt is highly experienced in both convertible notes and equity investment instruments. In addition, she has negotiated dozens of exits and conversions of debt to equity. Hartt holds a Master’s in Biology (with a focus on molecular biology and genetics) and Bachelor’s degree in Biology, graduating summa cum laude and Phi Beta Kappa, with both degrees from the University of Pennsylvania.